Dr. Leslie Marisol Lugo Gavidia, MD, MSc. Graduate of
Queretaro ́s Autonomous University; Mexico 2014 and
certified as a medical doctor (M.D.) she continued her
training on cardiovascular research in the Queretaro´s heart
institute and participated in national projects focusing on
projects to improve coronary artery disease diagnosis,
treatment and prognosis. She obtained her Master´s degree
in biomedical science (2017) on which she focused on the
evaluation of platelet´s receptor polymorphisms and
platelet aggregation in coronary artery disease. Following
this she did a fellowship in Barcelona at the Bellvitge
Biomedical Research Institute (IDIBELL) in the Bellvitge
University Hospital focused on antithrombotic therapy and coronary artery disease and
the impact to the long term outcome on this patients. She studied Design and statistics
in health sciences on Barcelona ́s Autonomous University. Currently PhD student at The
University of Western Australia.
Dr. Leslie Marisol Lugo Gavidia, MD, MSc. Graduate of
Queretaro ́s Autonomous University; Mexico 2014 and
certified as a medical doctor (M.D.) she continued her
training on cardiovascular research in the Queretaro´s heart
institute and participated in national projects focusing on
projects to improve coronary artery disease diagnosis,
treatment and prognosis. She obtained her Master´s degree
in biomedical science (2017) on which she focused on the
evaluation of platelet´s receptor polymorphisms and
platelet aggregation in coronary artery disease. Following
this she did a fellowship in Barcelona at the Bellvitge
Biomedical Research Institute (IDIBELL) in the Bellvitge
University Hospital focused on antithrombotic therapy and coronary artery disease and
the impact to the long term outcome on this patients. She studied Design and statistics
in health sciences on Barcelona ́s Autonomous University. Currently PhD student at The
University of Western Australia.